# Ultragenyx Pharmaceutical Inc.: Form 8-K, filed Nov 5, 2024

- Company: [Ultragenyx Pharmaceutical Inc.](/companies/rare.md) (CIK 1515673)
- Form: 8-K
- Filed: 2024-11-05
- Accepted by EDGAR: Nov 5, 2024, 16:06 ET
- Period: 2024-11-05
- Accession: 0000950170-24-121459
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1515673/000095017024121459/rare-20241105.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1515673/000095017024121459/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1515673/000095017024121459/rare-20241105.htm

Filed Nov 5, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-121459. Last ingested by Listed: Nov 3, 2026, 19:02 ET. No prices; not investment advice.